398 related articles for article (PubMed ID: 25046533)
1. The blood-brain barrier: structure, function and therapeutic approaches to cross it.
Tajes M; Ramos-Fernández E; Weng-Jiang X; Bosch-Morató M; Guivernau B; Eraso-Pichot A; Salvador B; Fernàndez-Busquets X; Roquer J; Muñoz FJ
Mol Membr Biol; 2014 Aug; 31(5):152-67. PubMed ID: 25046533
[TBL] [Abstract][Full Text] [Related]
2. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
Vlieghe P; Khrestchatisky M
Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
[TBL] [Abstract][Full Text] [Related]
3. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
4. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
5. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
6. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophin delivery using nanotechnology.
Angelova A; Angelov B; Drechsler M; Lesieur S
Drug Discov Today; 2013 Dec; 18(23-24):1263-71. PubMed ID: 23891881
[TBL] [Abstract][Full Text] [Related]
8. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
[TBL] [Abstract][Full Text] [Related]
9. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
[TBL] [Abstract][Full Text] [Related]
10. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
11. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
12. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
13. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
14. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
Jain KK
Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
[TBL] [Abstract][Full Text] [Related]
15. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
Md S; Mustafa G; Baboota S; Ali J
Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
[TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
19. Current Strategies for Brain Drug Delivery.
Dong X
Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
[TBL] [Abstract][Full Text] [Related]
20. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]